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sequence was compared via BLAST search at the EzTaxon
public database. As a result of sequence comparison, strains
with the greatest pairwise similarity to strain ABB-Jeju-1
were E. tasmaniensis Et1/99T (98.9%), E. toletana A37T
(98.8%), and E. billingiae LMG 2613T (98.1%). A phyloge-
netic tree based on 16S rRNA gene sequences also suggested
that the strain ABB-Jeju-1 clustered with E. tasmaniensis
ET1/99T, which was supported moderately by the bootstrap
value (66%). Very recently, Stackbrandt and Ebers stated
that a strain with a 16S rRNA gene sequence similarity lower
than 99% with known species should be subjected to testing
as a novel species, by comparison of 16S rRNA gene sequence
similarities and DNA-DNA reassociation values. Accordingly,
strain ABB-Jeju-1 could not be regarded as E. tasmanien-
sis with conﬁdence, and we designated the strain as an E.
tasmaniensis-like organism.
Conclusions: This is the ﬁrst case of human infection due
to Erwinia tasmaniensis-like organism.
doi:10.1016/j.ijid.2008.05.881
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Background: Mortality of 1918 Spanish inﬂuenza in Taiwan
had only been brieﬂy reported around 25,000, causing 0.69%
death rate in previous literature. Here we present a detailed
epidemiology to comprehend its impact in Taiwan.
Methods: Historical records and publications of
‘‘Sotokufu’’ (Japanese colonial government in Taiwan)
era during 1912 to 1925 were reviewed to retrieve relevant
statistics and data. Death rates due to inﬂuenza and
pneumonia (P&I) or combined respiratory tract illnesses
(RTI), including P&I, acute or chronic bronchitis and others,
were calculated using populations of speciﬁc age groups
living in Taiwan based on an island-wide census in 1915
as denominators. Excess deaths were estimated using
the average mortality 5-year before the pandemic as the
baseline.
Results: Two sharp upsurges in P&I mortality by at least
7-fold were detected during October 1918 to January 1919
and December 1919 to March 1920, and resulted in more
than 17,000 and 21,000 excess deaths, respectively, as com-
pared to the same 4-month periods of 1912—1917. During
the pandemic years, annual deaths due to P&I and RTI were
at least 28,000 and 44,000 with mortality rates around 0.83%
and 1.24%, respectively. Annual P&I death rates, compared
to those of 1913—1917, increased disproportionately among
different ages: in 1918, the highest escalation was 5.2-fold
among the 20—30 year-olds and in 1920, 7.7-fold among the
5—10 year-olds; the least was 1.8- to 2.1- fold among the
60’s or older. Similar pattern and trend were detected when
RTI substituted for P&I in the analyses.
Conclusion: In this investigation of epidemiology of Span-
ish inﬂuenza in Taiwan, more than 60,000 P&I deaths in
2 waves separated by 10 months during 1918—1920 were
identiﬁed, with much higher mortality and death rate than
previously recognized. Similar to previous studies, this pan-
demic had resulted in an unusual high mortality to young
people in Taiwan.
doi:10.1016/j.ijid.2008.05.882
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Using vaccines to mitigate the effects of a new inﬂuenza
pandemic will be hindered by limited vaccine production
capacity and delays inherent in the production of inﬂuenza
vaccines. Antigen-sparing vaccines have the most poten-
tial to increase population coverage but this may require a
trade-off in protective efﬁcacy. We used mathematical mod-
elling to investigated this trade-off for vaccines that reduce
susceptibility and/or infectivity, and found that the optimal
dose can be low or high in antigen depending on the vaccine
characteristics and production supply. For published Phase I
trial data this occurs at low antigen levels. We also examined
the effect of timing on the vaccination campaign. With and
R 0 of 2, and early vaccination of 20% of the population,
the ﬁnal serological attack rate could be reduced by 12%
with a two-dose campaign. However, if vaccination was syn-
chronous with the epidemic starting, then one 7.5mcg dose
and two 3.8mcg doses to the same number of people had
similar results with around a 6% reduction in the ﬁnal attack
rate (results based on GSK adjuvanted candidate vaccines).
We also studied the effect of delays in vaccine availability,
distribution rate and time to seroconversion on epidemic
size with dynamic vaccine distribution during an epidemic
of inﬂuenza. We found that a rapid distribution campaign
can control a highly infectious virus if begun while there are
a small number of cases but that the effect is much reduced
by a delay of just 1 month. Our results suggest that anti-
gen sparing vaccines should continue to be pursued and that
if time is critical, a higher, single-dose schedule could be
used. It is important to vaccinate prior to the arrival of the
pandemic when pursuing a two-dose schedule.
doi:10.1016/j.ijid.2008.05.883
